February is Gallbladder Cancer and Bile Duct Cancer Awareness Month & National Cancer Prevention Awareness Month

AACR

Gallbladder cancer and bile duct cancer are relatively rare  with an estimated 12,350 cases of both types combined diagnosed in 2024, according to the National Cancer Institute (NCI). The  NCI estimated about 4,530 deaths  from these cancers in 2024.  Cancer of the gallbladder is one of the 15 forms of cancer that have been linked to being overweight or obese, according to the AACR Cancer Progress Report 2024. Disparities exist in the rates at which these cancers occur among minority populations. For example, Hispanic men and women are more than twice as likely as white men and women to be diagnosed with gallbladder cancer. Rates are also higher among Native American and Asian-Pacific Islander groups than among whites, according to the AACR Cancer Disparities Progress Report 2024. The five-year relative survival rates for gallbladder cancer range from 4% when the cancer is diagnosed at an advanced stage to 68% when diagnosed while the cancer is still localized. For bile duct cancers, the overall five-year relative survival rate is 11% for intrahepatic bile duct cancer and 21% for extrahepatic bile duct cancer. In recent years, incremental improvements in survival rates for biliary tract cancers have been achieved by molecularly targeted treatments.

© 2021 FLASCO | Premium Website Design by The HDG